Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luuk Gras

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
American Journal of Epidemiology|February 18, 2006
The effect on treatment comparisons of different measurement frequencies in human immunodeficiency virus observational databasesJames T Griffin, Christophe Fraser, Luuk Gras, et al.
AIDS (London, England)|February 19, 2011
Lower mortality and earlier start of combination antiretroviral therapy in patients tested repeatedly for HIV than in those with a positive first testLuuk Gras, Ard van Sighem, Daniela Bezemer, et al.
European Journal of Epidemiology|October 27, 2017
Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer's diseaseAlison K Ower, Christoforos Hadjichrysanthou, Luuk Gras, et al.
AIDS Research and Human Retroviruses|August 10, 2013
Loss to follow-up and mortality rates in HIV-1-infected patients in Curaçao before and after the start of combination antiretroviral therapyHillegonda Hermanides, Rebecca Holman, Luuk Gras, et al.
AIDS (London, England)|November 13, 2015
CD4+ cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, sex and calendar timeAnne Cori, Michael Pickles, Ard van Sighem, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2005
Mortality in patients with successful initial response to highly active antiretroviral therapy is still higher than in non-HIV-infected individualsArd van Sighem, Sven Danner, Azra C Ghani, et al.
Plos One|October 8, 2013
Changes in first-line cART regimens and short-term clinical outcome between 1996 and 2010 in The NetherlandsMikaela Smit, Colette Smit, Suzanne Geerlings, et al.
Acta Paediatrica (Oslo, Norway : 1992)|January 20, 2006
Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centresLuuk Gras, Martine Wallon, Arnold Pollak, et al.
Journal of the International AIDS Society|November 14, 2014
More virological failure with lamivudine than emtricitabine in efavirenz and nevirapine regimens in the Dutch nationwide HIV CohortCasper Rokx, Azzania Fibriani, David van de Vijver, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 2, 2011
Immunodeficiency as a risk factor for non-AIDS-defining malignancies in HIV-1-infected patients receiving combination antiretroviral therapyAnouk Kesselring, Luuk Gras, Colette Smit, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
American Journal of Epidemiology|February 18, 2006
The effect on treatment comparisons of different measurement frequencies in human immunodeficiency virus observational databasesJames T Griffin, Christophe Fraser, Luuk Gras, et al.
AIDS (London, England)|February 19, 2011
Lower mortality and earlier start of combination antiretroviral therapy in patients tested repeatedly for HIV than in those with a positive first testLuuk Gras, Ard van Sighem, Daniela Bezemer, et al.
European Journal of Epidemiology|October 27, 2017
Temporal association patterns and dynamics of amyloid-β and tau in Alzheimer's diseaseAlison K Ower, Christoforos Hadjichrysanthou, Luuk Gras, et al.
AIDS Research and Human Retroviruses|August 10, 2013
Loss to follow-up and mortality rates in HIV-1-infected patients in Curaçao before and after the start of combination antiretroviral therapyHillegonda Hermanides, Rebecca Holman, Luuk Gras, et al.
AIDS (London, England)|November 13, 2015
CD4+ cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, sex and calendar timeAnne Cori, Michael Pickles, Ard van Sighem, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 28, 2005
Mortality in patients with successful initial response to highly active antiretroviral therapy is still higher than in non-HIV-infected individualsArd van Sighem, Sven Danner, Azra C Ghani, et al.
Plos One|October 8, 2013
Changes in first-line cART regimens and short-term clinical outcome between 1996 and 2010 in The NetherlandsMikaela Smit, Colette Smit, Suzanne Geerlings, et al.
Acta Paediatrica (Oslo, Norway : 1992)|January 20, 2006
Association between prenatal treatment and clinical manifestations of congenital toxoplasmosis in infancy: a cohort study in 13 European centresLuuk Gras, Martine Wallon, Arnold Pollak, et al.
Journal of the International AIDS Society|November 14, 2014
More virological failure with lamivudine than emtricitabine in efavirenz and nevirapine regimens in the Dutch nationwide HIV CohortCasper Rokx, Azzania Fibriani, David van de Vijver, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 2, 2011
Immunodeficiency as a risk factor for non-AIDS-defining malignancies in HIV-1-infected patients receiving combination antiretroviral therapyAnouk Kesselring, Luuk Gras, Colette Smit, et al.
Pageof 8